PD-L1 Detection in Tumors Using [(64)Cu]Atezolizumab with PET.

PD-L1 Detection in Tumors Using [(64)Cu]Atezolizumab with PET.

Item
http://www.wikidata.org/entity/Q37621295
Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab.Cell genomics and immunosuppressive biomarker expression influence PD-L1 immunotherapy treatment responses in HNSCC-a computational study.Advancing Immune and Cell-Based Therapies Through Imaging.Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician.Noninvasive Imaging of Immune Checkpoint Ligand PD-L1 in Tumors and Metastases for Guiding Immunotherapy.Imaging PD-L1 Expression with ImmunoPET.Rapid PD-L1 detection in tumors with PET using a highly specific peptide.Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanoma.Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and Beyond
P2860

PD-L1 Detection in Tumors Using [(64)Cu]Atezolizumab with PET.

Item
http://www.wikidata.org/entity/Q37621295
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PD-L1 Detection in Tumors Using [
@nl
PD-L1 Detection in Tumors Using [(64)Cu]Atezolizumab with PET.
@en
type
label
PD-L1 Detection in Tumors Using [
@nl
PD-L1 Detection in Tumors Using [(64)Cu]Atezolizumab with PET.
@en
prefLabel
PD-L1 Detection in Tumors Using [
@nl
PD-L1 Detection in Tumors Using [(64)Cu]Atezolizumab with PET.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
PD-L1 Detection in Tumors Using [(64)Cu]Atezolizumab with PET.
@en
P2093
P2860
P304
P31
P356
10.1021/ACS.BIOCONJCHEM.6B00348
P433
P478
P50
P577
P698
P921
P932